• Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a)

  • 2024/11/18
  • 再生時間: 14 分
  • ポッドキャスト

Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a)

  • サマリー

  • Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic’s Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration.

    Related Content:

    • Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
    続きを読む 一部表示

あらすじ・解説

Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic’s Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration.

Related Content:

  • Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)

Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a)に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。